DrugDashboards

Alka-Seltzer Extra Strength Pain Relief

Anhydrous Citric Acid, Aspirin · CAFFEINE 65 mg/1; ASPIRIN 500 mg/1 · Tablet, Effervescent · Oral · Bayer HealthCare LLC.

NDC 00280-8260-20 · 10 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
M013
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Anhydrous Citric Acid, Aspirin (Tablet, Effervescent)

LabelerStrengthFirst seenLast seen
Bayer HealthCare LLC.CAFFEINE 65 mg/1; ASPIRIN 500 mg/1Aug 26, 2026Sep 2, 2026
Bayer HealthCare LLC.CAFFEINE 500 mg/1; ASPIRIN 65 mg/1Jul 22, 2026Aug 19, 2026
Bayer HealthCare LLC.ASPIRIN 500 mg/1; CAFFEINE 65 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Alka-Seltzer Extra Strength Pain Relief — NDC 00280-8260-20," retrieved September 3, 2026, https://drugdashboards.com/drug/00280826020.

Free to cite with attribution — see how the data is put together.